Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  Beijing SL Pharmaceutical Co Ltd    002038   CNE000001L31

No quotes available
-- CNY   --.--%
2015 BEIJING SL PHAR : 2014 Net Up 20%
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Beijing SL Pharmaceutical
Produces and supplies pharmaceutical products

Beijing SL Pharmaceutical Co. Ltd. engages in the development and marketing gene engineering drugs.

Its products include Li Sheng Su, a recombinant human Granulocyte Colony-stimulating Factor (rhG-CSF) injection; Mai Ge Er, a recombinant human Interleukin-11 (rhIL-11) injection; and Xin Ji Er, a recombinant human Ala Interleukin-2 (Ala IL-2) injection.

The company was founded by Ming Bo Xu in December 1994 and is headquartered in Beijing, China.

Number of employees : 629 persons.
Sales per Businesses
20132014Delta
CNY (in Million)%CNY (in Million)%
Bio-Pharmaceutical981.0284.5%1,01381.5% +3.14%
Biochemical131.5311.3%158.4212.7% +16.97%
Other35.003%35.752.9% +2.11%
Other Business14.231.2%36.002.9% +60.49%
Sales per Regions
20132014Delta
CNY (in Million)%CNY (in Million)%
China1,161100%1,243100% +6.57%
Managers
NameAgeSinceTitle
Mingbo Xu, PhD52-Chairman & President
Anjing Lu59-Chairman-Supervisory Board
Wenying Xi53-Chief Financial Officer
Yu Lin Chen71-Director
Xiu Jiang Wen39-Director-Supervisory Board
Qing Jun Ma80-Independent Director
Su Yan Wei64-Independent Director
Ming Xi Zhang, CPA462007Independent Director
Shujie Liang50-Board Secretary
Yong Bo Wang41-Vice President
Shareholders
NameEquities%
Xinxiang Bureau of Finance 144,412,994 25.5%
Mingbo Xu, PhD 38,615,252 6.81%
China Resources SZITIC Trust Co., Ltd. 25,200,144 4.44%
Bin Wang 8,787,900 1.55%
Pacific Asset Management Co., Ltd. 4,449,335 0.78%
Norges Bank Investment Management 3,945,485 0.70%
Norges Bank Investment Management (China) 3,945,486 0.70%
Shanghai Broadvision Investment Management Co. Ltd. 3,437,429 0.61%
Yi Chao Wang 3,106,070 0.55%
Kuwait Investment Authority (Investment Management) 3,063,705 0.54%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
GILEAD SCIENCES, ..
AMGEN, INC.
CELGENE CORPORATI..
REGENERON PHARMAC..
VERTEX PHARMACEUT..
SHANGHAI RAAS BLO..
-
ACTELION LTD
GENMAB A/S
MEDIVATION INC
TONGHUA DONGBAO P..
HUALAN BIOLOGICAL..
3SBIO INC
-
NEUROCRINE BIOSCI..
CHINA BIOLOGIC PR..
JUNO THERAPEUTICS..
BEIJING SL PHARMA..
ZHONGYUAN UNION C..
INTERCEPT PHARMAC..
VIROMED CO LTD
-
ULTRAGENYX PHARMA..
-
Sector Biotechnology & Medical Research
Beijing SL Pharmaceutical : Connections
Beijing Society of Biotechnology
Chinese Society of Biotechnology
Beijing Institute of Technology
Xinxiang Bailu Chemical Fiber Group Co. Ltd.
Beijing Jurassic Software Co., Ltd.
Accounting Society of China
Company contact information
Beijing SL Pharmaceutical Co., Ltd.
9 Zhongyuan Road
Bada High Development District
Beijing 100041

Phone : +86.10.8879.9370
Fax : +86.10.8879.5883
Web : www.slpharm.com.cn
© 2016 People , Fundamentals and Ownership